This transcript has been edited for clarity.
Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm Dr Silvio Inzucchi, and today we're talking about obesity and type 2 diabetes. It's a long-standing concern, but one with a great deal of potential for success on the horizon, which we'll talk about very shortly.
First, let me introduce my guest, who is an obesity expert and a colleague of mine: Dr Ania Jastreboff. She is associate professor of medicine at Yale School of Medicine and director of Yale Weight Management and Obesity Prevention at the Yale Stress Center. In addition to being an endocrinologist for both adults and children, she's also board-certified in obesity medicine. We're very fortunate today to have a true expert with us. Welcome, Ania.
Ania Jastreboff, MD, PhD: Thanks for having me, Silvio. It's my pleasure to be here today.
Inzucchi: Before we get into our main discussion, can you tell us a little bit about why you got into working in the field of obesity medicine?
Jastreboff:Deep down from the very beginning, I never thought that obesity was not a disease, and I didn't understand why we didn't treat it as such. Looking at what we had advised our patients for years in terms of moving more and eating less, is that how we advise for any other disease?
